AAM CEO: Generic Price Increases Will Not ‘Fly Under The Radar’

February 05, 2019
NEW ORLEANS — Association for Accessible Medicines President and CEO Chip Davis told generic drug industry players Tuesday (Feb. 5) that politicians and Trump administration officials have no tolerance for price increases on generic prescription drugs, even though some have voiced concerns about generic drug prices being too low. AAM has argued in the past that CMS payments for generic drugs are unsustainably low . Davis said he received more than one call from administration officials asking “pointed questions” about...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.